Covidien Ltd Wins FDA OK For Generic Heart Image Agent

February 27, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CHICAGO, Feb 27 (Reuters) - Healthcare products company Covidien said on Wednesday the U.S. Food and Drug Administration granted tentative approval for its generic imaging agent used for detecting coronary artery disease.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals

Food and Drug Administration (FDA)